Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus
09:25am, Monday, 05'th May 2025
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Quest Diagnostics: A Leader But Waiting For Better Price
04:26am, Saturday, 03'rd May 2025
Quest Diagnostics excels in scale, scope, and service quality, leveraging automation and distribution to reduce costs and offer comprehensive test menus. Despite its strengths, I recommend waiting to
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
01:17pm, Wednesday, 23'rd Apr 2025
Quest Diagnostics Incorporated DGX posted better-than-expected first-quarter earnings on Tuesday.
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
12:09pm, Tuesday, 22'nd Apr 2025
Quest Diagnostics Inc DGX reported on Tuesday that first-quarter 2025 sales of $2.65 billion, up 12.1% year over year, beat the consensus of $2.63 billion.
Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript
11:39am, Tuesday, 22'nd Apr 2025
Quest Diagnostics Incorporated (NYSE:DGX ) Q1 2025 Results Conference Call April 22, 2025 8:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Jim Davis - Chairman, Chief
Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up
11:35am, Tuesday, 22'nd Apr 2025
DGX delivers solid top-line growth in the first quarter of 2025.
Quest Diagnostics (DGX) Q1 Earnings and Revenues Beat Estimates
08:55am, Tuesday, 22'nd Apr 2025
Quest Diagnostics (DGX) came out with quarterly earnings of $2.21 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.04 per share a year ago.
Quest beats quarterly profit estimates on strong demand for diagnostic tests
07:37am, Tuesday, 22'nd Apr 2025
Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter
07:01am, Tuesday, 22'nd Apr 2025
Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.
First quarter revenues of $2.65 billion, up 12.1% from 2024 First quarter reported diluted earnings per share ("EPS") of $1.94, up 12.8% from 2024; and adjusted diluted EPS of $2.21, up 8.3% from 2024
Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?
11:06am, Tuesday, 15'th Apr 2025
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings
10:31am, Tuesday, 15'th Apr 2025
DGX's first-quarter 2025 performance is likely to have been supported by the ongoing utilization of its Advanced Diagnostics and benefits from acquisitions.
DGX Stock Gains Following the Launch of New AD-Detect Blood Test
07:45am, Friday, 11'th Apr 2025
Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET imaging and cerebral spinal fluid testing.
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
07:53am, Wednesday, 09'th Apr 2025
In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and s
T-Mobile Leads Five Stocks To Watch As Market Correction Intensifies
08:00am, Saturday, 05'th Apr 2025
This weekend's stocks to watch are defensive plays. They boast strong relative strength, but still suffered losses amid the market sell-off.
